Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma.
about
Influenza vaccines in immunosuppressed adults with cancerVaccines for prophylaxis of viral infections in patients with hematological malignanciesVaccines for prophylaxis of viral infections in patients with hematological malignanciesVaccination recommendations for the hematology and oncology and post-stem cell transplant populationsInfluenza vaccination in cancer patients undergoing systemic therapyEpidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factorsInfluenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and SafetyInfluenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspectiveHow I treat influenza in patients with hematologic malignancies.The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies.Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma.Evaluation of vaccine dosing in patients with solid tumors receiving myelosuppressive chemotherapy.Efficacy of the influenza vaccine in patients with malignant lymphoma2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.Immunization recommendations for adults with cancer.Influenza a outbreak in an ambulatory stem cell transplant center.Pneumococcal vaccination and revaccination of older adults.Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance.Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancerLongitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study.Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine eraEuropean Myeloma Network guidelines for the management of multiple myeloma-related complications.Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).Practical review of immunizations in adult patients with cancer.Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia.Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.Immunodeficiency and immunotherapy in multiple myeloma.Immune therapies.Influenza vaccination in hematopoietic SCT recipients.Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responsesDendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection.State-of-the-Art Management of Complications of Myeloma and Its Treatment.Guidelines for supportive care in multiple myeloma 2011.Using antimicrobial adjuvant therapy in cancer treatment: a review.Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma.International Myeloma Working Group recommendations for global myeloma care.Pneumococcal immunization in immunocompromised hosts: where do we stand?
P2860
Q24202869-2A6D8BBB-692B-43FA-9D74-0A72553F100BQ24235812-DC0DF66E-E2E6-4C01-BC25-1B1971A493BEQ24245832-F276862F-89E6-47FD-87DC-0B8D8A1B6897Q26829398-19819304-A318-40CB-9298-E18E0C1048A5Q27027645-69109563-0E86-4142-91D5-27B24CB73716Q27685556-5D04FB82-7FEC-4188-9403-9E8A0EAB5F5FQ28079486-2A673C02-7489-46F1-A23D-25B71023C198Q28740919-E10C0AED-90B6-4F22-9981-75C30344C246Q30383456-415F7987-EEB1-4752-8C09-701D6E0C4D87Q30403660-71ACBCAE-99CC-4E8C-8DC6-930A64B72C7CQ33203486-FBF45484-A5C0-44A4-A274-4FF9E3586615Q33259460-62868C16-F53D-4D1B-BEFA-60EFCE7423D1Q34146495-1CF146D1-298B-4496-8A66-FA5887EF81E9Q34390072-E68617E9-387A-406E-BD8D-073DD3C62877Q34568939-F160D1E7-70E5-4E2E-8EE7-5D7B6DEC2AF6Q34709861-97146DEC-7E8B-4CFF-8EEA-E45B94E6BBCAQ34801940-48E628CC-5DC7-4B5B-91D1-681C08A94F1AQ34926870-8603A476-BB7A-40EC-9B4C-6AFC021AC291Q35066433-1CAE4D39-3F35-45BB-A7F1-D137E6AC2713Q35705166-E38D938C-14AB-434D-A327-03DF38FCA3FDQ35846308-483C8C61-027F-4ABD-9B61-BCE0C6575EA7Q35863376-BD0233C5-5D06-445F-A12E-FDF4CF00D489Q35940648-ADA4C8FE-3287-432C-ACDC-7FBD0AED3984Q36115636-55C8D336-BC6E-427D-93BB-EA99AFE6E3B0Q36367268-14315187-8758-4C54-BFEA-D4C6880641DBQ36388960-EFEDC0FF-F507-480F-8AF2-D0B9D7CA94CCQ36493907-641E369E-A3A6-49F9-B5E8-4FF4A5AB194AQ36764389-604C0405-C9D2-4363-8EF1-52567035BA85Q36861572-982C21ED-4734-4EC5-BCED-F9C38CA37F53Q36904977-74A10C67-F0E1-4431-BD16-840D2F0007CAQ36998232-6BC05EB3-1B62-476F-9C8A-8F7540CFEE9FQ37251090-5FD2747F-80FC-4655-8FC6-BCD63A1DDCD2Q37416103-E64E4517-FC33-4F2E-AF4B-906703BE479FQ37771941-6C670CC2-C8C3-4B24-99E6-F39C044A69A1Q37776662-78BEDDFD-6B64-460C-A68E-C9286EAF694BQ37868637-E35B03C4-5CE5-4D40-A34E-1283C83B0F5EQ38060894-A0FE3AE0-1F4C-416E-ADC6-7EC84BA4D47BQ38155039-66C5422C-47D3-4DB3-A35C-39A9C760223DQ38157532-66E7315C-525A-4350-B9E6-80017362637CQ38168902-9327BFD6-75D1-47D6-95AD-E1C61B417B07
P2860
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Immunogenicity of vaccination ...... atients with multiple myeloma.
@ast
Immunogenicity of vaccination ...... atients with multiple myeloma.
@en
type
label
Immunogenicity of vaccination ...... atients with multiple myeloma.
@ast
Immunogenicity of vaccination ...... atients with multiple myeloma.
@en
prefLabel
Immunogenicity of vaccination ...... atients with multiple myeloma.
@ast
Immunogenicity of vaccination ...... atients with multiple myeloma.
@en
P2093
P2860
P356
P1476
Immunogenicity of vaccination ...... atients with multiple myeloma.
@en
P2093
Anderson H
Robertson JD
Scarffe JH
P2860
P2888
P304
P356
10.1054/BJOC.1999.1088
P407
P577
2000-04-01T00:00:00Z
P5875
P6179
1048335389